Med. Klinik m.S. Hämatologie und Onkologie

Berlin 13353

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myeloid, Acute

Studies at this site

• Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) — Completed